Evaluation of intrapatient variability in bioavailability of Technosphere insulin compared with subcutaneous regular insulin in patients with type 2 diabetes.

Trial Profile

Evaluation of intrapatient variability in bioavailability of Technosphere insulin compared with subcutaneous regular insulin in patients with type 2 diabetes.

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Jun 2011

At a glance

  • Drugs Insulin; Insulin
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors MannKind Corporation
  • Most Recent Events

    • 28 Jun 2011 Actual end date (Mar 2005) added as reported by ClinicalTrials.gov.
    • 14 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top